Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
home:patients:protocol_overview [06.24.2019]
sallieq [Introduction to the Marshall Protocol]
home:patients:protocol_overview [01.16.2020]
sallieq
Line 5: Line 5:
  
  
-The Marshall Protocol, sometimes referred to as the MP, was developed by a team led by Trevor Marshall, PhD, as an antimicrobial treatment for chronic inflammatory diseases. Most diseases of unknown cause are chronic inflammatory diseases, and almost 100% of patients with these diseases have responded to the treatment. On this site and others, chronic inflammatory diseases are sometimes referred to as the Th1 diseases.+The Marshall Protocol, sometimes referred to as the MP, was developed by a team led by Trevor Marshall, PhD, as an antimicrobial treatment for chronic inflammatory diseases. Most diseases of unknown cause are chronic inflammatory diseases, and over 85% of patients with these diseases have responded to the treatment. On this site and others, chronic inflammatory diseases are sometimes referred to as the Th1 diseases.
  
 Treatment on the MP requires a [[home:​patients:​mp_duration|number of years]] to complete, but the exact duration is determined by degree of illness and any unavoidable immune suppressants to which the patient is exposed. Treatment on the MP requires a [[home:​patients:​mp_duration|number of years]] to complete, but the exact duration is determined by degree of illness and any unavoidable immune suppressants to which the patient is exposed.
home/patients/protocol_overview.txt · Last modified: 01.16.2020 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.